• Director Donald Allen Williams increased his direct stake in Palisade Bio to 1,590,294 common shares through open-market purchases.
• The shares were bought at prices of USD 1.42 and USD 1.46.
• He also reported 3,000 common shares held indirectly through his defined benefit plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-045772), on October 05, 2026, and is solely responsible for the information contained therein.